Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
PharmaResearch Co Ltd banner
P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 345 000 KRW -1%
Market Cap: ₩3.6T
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
PharmaResearch Co Ltd

Wall Street analysts forecast PharmaResearch Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 728 280 KRW with a low forecast of 646 400 KRW and a high forecast of 843 150 KRW.

Lowest Forecast
Wall Street Target
646 400 KRW
87% Upside
Average Forecast
Wall Street Target
728 280 KRW
111% Upside
Highest Forecast
Wall Street Target
843 150 KRW
144% Upside
Lowest
Price Target
646 400 KRW
87% Upside
Average
Price Target
728 280 KRW
111% Upside
Highest
Price Target
843 150 KRW
144% Upside
PharmaResearch Co Ltd Competitors:
Price Targets
TCPC
BlackRock TCP Capital Corp
37% Upside
INBK
First Internet Bancorp
28% Upside
APA
APA Corp (US)
-5% Downside
KRNY
Kearny Financial Corp
15% Upside
TCPC
BlackRock TCP Capital Corp
37% Upside
INBK
First Internet Bancorp
28% Upside
APA
APA Corp (US)
-5% Downside
KRNY
Kearny Financial Corp
15% Upside
F
FLB
Fluidigm Corp
30% Upside

Revenue
Forecast

30% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
30% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 30%. The projected CAGR for the next 3 years is 36%.

What are analyst estimates?

Operating Income
Forecast

27% / Year
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
27% / Year
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 27%. The projected CAGR for the next 3 years is 43%.

What are analyst estimates?

Net Income
Forecast

26% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss
26% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-12%
Average Miss

For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 26%. The projected CAGR for the next 3 years is 46%.

What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PharmaResearch Co Ltd's stock price target?
Price Target
728 280 KRW

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 728 280 KRW with a low forecast of 646 400 KRW and a high forecast of 843 150 KRW.

What is PharmaResearch Co Ltd's Revenue forecast?
Projected CAGR
36%

For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's revenue is 30%. The projected CAGR for the next 3 years is 36%.

What is PharmaResearch Co Ltd's Operating Income forecast?
Projected CAGR
43%

For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's operating income is 27%. The projected CAGR for the next 3 years is 43%.

What is PharmaResearch Co Ltd's Net Income forecast?
Projected CAGR
46%

For the last 10 years the compound annual growth rate for PharmaResearch Co Ltd's net income is 26%. The projected CAGR for the next 3 years is 46%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.